HECTOR ABELARDO OCAMPO | Pharmaceutical Science | Excellence in Research

Posted on by ScienceFather

Dr. HECTOR ABELARDO OCAMPO | Pharmaceutical Science | Excellence in Research

Dr. HECTOR ABELARDO OCAMPO, Instituto Politécnico Nacional, Mexico

Dr. Héctor Abelardo González Ocampo is a dedicated researcher and full-time professor at the Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional, focusing on sustainable aquaculture technologies. His innovative work includes developing microencapsulated phenolic extracts as antioxidant and immunostimulant additives in aquaculture diets. He holds several patents related to biotechnological additives and environmental impact. Dr. González supervises master’s and doctoral students in natural resource management and biotechnology, contributing significantly to academic development. His recent graduates have explored topics related to environmental health risks associated with marine species. 🌱🐟📚

Publication Profile

Google Scholar

Academic Experience and Contributions

Dr. Ocampo has a substantial teaching portfolio. He imparts knowledge in environmental impact and ecotoxicology to graduate students, thereby shaping the next generation of researchers in environmental sciences. His commitment to education ensures that his research impacts future leaders in sustainable practices and policies.

 

Conclusion

Dr. Héctor Abelardo Ocampo’s multifaceted expertise in sustainable aquaculture technologies, public health risk assessment, and his strong academic and patent record positions him as an exemplary candidate for the Research for Best Researcher Award. His work not only advances scientific knowledge but also contributes to practical solutions in environmental sustainability and public health safety, aligning perfectly with the award’s objectives.

Publication Top Notes  

  • Las áreas naturales protegidas de México 🌳 | Cited by: 91 | Year: 2014
  • The prebiotic inulin increases the phenoloxidase activity and reduces the prevalence of WSSV in whiteleg shrimp (Litopenaeus vannamei) cultured under laboratory conditions 🍤 | Cited by: 77 | Year: 2012
  • Effect of inulin and probiotic bacteria on growth, survival, immune response, and prevalence of white spot syndrome virus (WSSV) in Litopenaeus vannamei 🦠 | Cited by: 57 | Year: 2013
  • Microbial immunostimulants reduce mortality in whiteleg shrimp (Litopenaeus vannamei) challenged with Vibrio sinaloensis strains ⚠️ | Cited by: 54 | Year: 2011
  • Mangrove forest and artisanal fishery in the southern part of the Gulf of California, Mexico 🌊 | Cited by: 51 | Year: 2013
  • Growth, survival, and superoxide dismutase activity in juvenile Crassostrea corteziensis (Hertlein, 1951) treated with probiotics 🦪 | Cited by: 44 | Year: 2009
  • Human health risk assessment of pesticide residues in snappers (Lutjanus) fish from the Navachiste Lagoon complex, Mexico ⚠️ | Cited by: 38 | Year: 2015
  • Protective effect of microbial immunostimulants and antiviral plants against WSSV in Litopenaeus vannamei cultured under laboratory conditions 🌱 | Cited by: 37 | Year: 2014
  • Dietary microorganism and plant effects on the survival and immune response of Litopenaeus vannamei challenged with the white spot syndrome virus 🍃 | Cited by: 35 | Year: 2011
  • Isolation and characterization of infectious Vibrio sinaloensis strains from the Pacific shrimp Litopenaeus vannamei (Decapoda: Penaeidae) 🔬 | Cited by: 34 | Year: 2012

Guanwei Fan | Cardiovascular research | Best Researcher Award

Posted on by ScienceFather

Prof. Guanwei Fan | Cardiovascular research | Best Researcher Award

Prof. Guanwei Fan, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China

Prof. Guanwei Fan, PhD, is a prominent researcher at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China. His research focuses on the molecular pharmacology of traditional Chinese medicine in cardiovascular diseases. Prof. Fan has received numerous accolades, including recognition as a national “WR” scientific and technological innovation talent and ranking among the top 2% of scientists globally in recent years. He has published extensively, contributing significantly to the understanding of cardiac repair and treatment methodologies. With a strong commitment to advancing traditional medicine, he continues to impact the field profoundly. 📚❤️

 

Publication Profile

Scopus

Education

Prof. Guanwei Fan obtained his Doctoral degree from Tianjin University of Traditional Chinese Medicine (09/2005-06/2008) after earning his Master’s degree from the same institution (09/2002-07/2005). His academic background provides a solid foundation for his research endeavors in traditional Chinese medicine.

Research Direction

Prof. Fan specializes in the molecular pharmacology of traditional Chinese medicine, specifically in the context of cardiovascular diseases. His focus on this area demonstrates his commitment to bridging traditional practices with modern scientific methodologies, contributing valuable insights to the field of pharmacology.

Academic and Professional Achievements

Prof. Fan has garnered significant recognition for his contributions to research and innovation. He has been selected as a national “WR” scientific and technological innovation leading talent and enjoys special government subsidies from The State Council. He is also a national candidate for the Millions of Talents Project and has been recognized as a young and middle-aged scientific and technological innovation leading talent by the Ministry of Science and Technology. Additionally, he holds the title of the first Young Qihuang Scholar and has received multiple accolades, including Tianjin Outstanding Youth and Jinmen Medical Talents. Notably, he ranked among the top 2% of the world’s top scientists in the “Impact of 2022” and “Impact of 2021” lists.

Conclusion

Prof. Guanwei Fan is a highly suitable candidate for the Research for Best Researcher Award. His innovative approach to integrating traditional Chinese medicine with modern pharmacological research in cardiovascular diseases sets him apart as a leading figure in his field.

 

Publication Top Notes  

  • Zhang, K., Yin, Z., Chen, F., … Wang, Y., Fan, G. Omics-based pharmacological evaluation reveals Yuanhu Zhitong oral liquid ameliorates arthritis by regulating PKC/ERK/NF-κB signaling pathway. Journal of Ethnopharmacology, 2024. 📖
  • Liu, Z., Bian, X., Li, L., … Liu, X., Fan, G. SENP1-Mediated HSP90ab1 DeSUMOylation in Cardiomyocytes Prevents Myocardial Fibrosis by Paracrine Signaling. Advanced Science, 2024. 📖
  • Lin, J., Chen, Y., Luo, X., Fan, G. Research hotspots and trends of traditional Chinese and western medicine in treatment of heart failure with preserved ejection fraction. Chinese Traditional and Herbal Drugs, 2024. 📖
  • Feng, C., Jiang, H., Fan, G., Li, L., Feng, J. Retrospective Study on the Efficacy of Qi Li Qiang Xin Jiao Nang in Reducing the Risk of Diuretic Resistance in Patients with Acute Decompensated Chronic Heart Failure. Chinese General Practice, 2024. 📖
  • Shi, J., Yang, M.M., Yang, S., … Fan, G., Ma, C. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLR−/− mice. Phytomedicine, 2024. 📖
  • Li, Z., Lyu, C., Pan, G., … Zhang, B., Huang, Y., Fan, G. Strategies and methods for studying interaction between traditional Chinese and western medicine dominated by clinical benefit-risk signals. Chinese Traditional and Herbal Drugs, 2024. 📖
  • Zhang, K., Ji, J., Li, N., Yin, Z., Fan, G. Integrated Metabolomics and Gut Microbiome Analysis Reveals the Efficacy of a Phytochemical Constituent in the Management of Ulcerative Colitis. Molecular Nutrition and Food Research, 2024. 📖
  • Zhao, Y., Zheng, G., Yang, S., … Fan, G., Ma, C. The plant extract PNS mitigates atherosclerosis via promoting Nrf2-mediated inhibition of ferroptosis through reducing USP2-mediated Keap1 deubiquitination. British Journal of Pharmacology, 2024. 📖
  • Wu, L.-L., Yang, B.-R., Meng, X.-Y., Fan, G.-W., Yang, B. Editorial: Artificial intelligence: new hope for critically ill cardiovascular patients. Frontiers in Medicine, 2024. 📖
  • Zhang, L., Lin, J., Zhang, C., … Fan, G., He, F. Recent Advances in the Nanotechnology-Based Applications of Essential Oils. Current Nanoscience, 2024. 📖

 

 

 

Gopal Natesan | Medicinal Chemistry | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Gopal Natesan | Medicinal Chemistry | Best Researcher Award

Prof Dr. Gopal Natesan, Institute of Pharmacy, Nirma University, India

Prof. Dr. Gopal Natesan is a distinguished academic and researcher in pharmaceutical chemistry, currently serving as Professor & Director at the Institute of Pharmacy, Nirma University, India. He holds a Ph.D. from Hamdard University and an MBA from MAHSA University. His research focuses on the synthesis of biologically active compounds and pharmacological evaluations. Dr. Natesan has received numerous accolades, including the “Most Trusted & Innovative Researcher in Asia” award in 2023 and the “Outstanding Scientist Award” in 2022. With a strong industrial background, he promotes research innovation and academic excellence. 🧪📚

Publication profile

Google Scholar

Educational Qualifications

Prof. Dr. Gopal Natesan boasts an impressive educational background. He earned his Ph.D. in Pharmaceutical Chemistry from Hamdard University in 2001. He also holds an M. Pharmacy from JSS College of Pharmacy (1996) and a B. Pharmacy from JKK Nataraja College of Pharmacy (1993), both affiliated with The Tamilnadu Dr. MGR Medical University. In 2016, he completed a Post Graduate Certificate in Teaching & Learning at Anglia Ruskin University, UK, and became a Fellow of The Higher Education Academy. Most recently, he obtained an MBA from MAHSA University in 2022. 📚🔬

 

Honors & Awards

Prof. Dr. Gopal Natesan has received numerous prestigious awards for his contributions to pharmaceutical science and education. In 2023, he was honored as the “Most Trusted & Innovative Researcher in Asia” at the ASIA-GCC Awards. His accolades include the “Outstanding Scientist Award” in 2022 and the “Edward Kennedy Memorial Award” in 2017. He has also received multiple best presentation and paper awards at international conferences, reflecting his commitment to excellence in research. Additionally, he was recognized with a Vice-Chancellor Award for outstanding performance in his MBA program, showcasing his academic prowess. 🌟🎓

 

Employment History

Prof. Dr. Gopal Natesan has served as Professor and Director at the Institute of Pharmacy, Nirma University, Ahmedabad, India. In this role, he manages operational activities, ensuring efficient administration and resource utilization. He oversees academic programs, maintaining high standards in teaching and curriculum development. Dr. Natesan is dedicated to faculty development, fostering continuous learning and research engagement. He enhances student experiences through support services and extracurricular activities while ensuring quality assurance through compliance with academic standards. Additionally, he promotes research innovation by securing grants and encouraging collaborations with industry and academia. 🌟🔬

Industrial Experience

Prof. Dr. Gopal Natesan has valuable industrial experience in the pharmaceutical sector. From November 2000 to January 2002, he worked as a Research Scientist at Ranbaxy Research Laboratory in Gurgoan, New Delhi, where he contributed to innovative pharmaceutical research. Following this, he served as a Research Associate at Orchid Chemicals & Pharmaceuticals Ltd in Chennai from January 2002 to February 2004. In these roles, he developed essential skills in research methodologies and project management, further enhancing his expertise in medicinal chemistry and pharmaceutical sciences. His industrial background complements his academic leadership, bridging theory and practice. 💼✨

 

Research Interests

Prof. Dr. Gopal Natesan specializes in medicinal chemistry, focusing on the synthesis and characterization of biologically active new chemical entities with five or six-member heterocyclic ring systems. His research includes the pharmacological evaluation of synthesized compounds, ensuring their potential therapeutic applications. Additionally, he is dedicated to the isolation and characterization of active constituents from plant sources, highlighting the importance of natural products in drug discovery. Dr. Natesan also explores pharmaceutical marketing management, integrating scientific research with practical applications in the pharmaceutical industry. 🌱💊

 

Publication Top Notes  

 

  • Hepatoprotective activity of Clerodendrum inerme against CCl4 induced hepatic injury in rats – Cited by: 85, Year: 2008 📄
  • Simultaneous estimation of paracetamol and aceclofenac in combined dosage forms by RP-HPLC method – Cited by: 44, Year: 2007 💊
  • Synthesis and Antibacterial Activity of Some Imidazole‐5‐(4H)one Derivatives – Cited by: 32, Year: 2005 🦠
  • Synthesis, characterization and antimicrobial activity of some novel Schiff and Mannich bases of isatin – Cited by: 22, Year: 2014 ✨
  • Antipyretic and analgesic effects of the aqueous extracts of Prosopis cineraria – Cited by: 22, Year: 2011 🌿
  • Quantitative estimation of lopinavir and ritonavir in tablets by RP-HPLC method – Cited by: 19, Year: 2012 💊
  • Simultaneous estimation of levocetirizine, ambroxol, phenylpropanolamine and paracetamol in combined dosage forms by RP-HPLC method – Cited by: 17, Year: 2006 📊
  • Anti-inflammatory activity of newly synthesised N-[4’-Oxo-2’-(substituted aryl/heteryl)-thiazolidin-3’-yl]-3-carboxamido-2H-chromen-2-one derivatives – Cited by: 15, Year: 2011 🔍
  • UV-Spectrophotometric Determination of Esomeprazole in tablet dosage forms – Cited by: 14, Year: 2007 💡
  • Effect of pollen substitute and two queen system on royal jelly production in Apis Mellifera L – Cited by: 13, Year: 1996 🐝
  • A validated HPTLC method for the estimation of donepezil HCL in bulk and its tablet dosage form – Cited by: 12, Year: 2011 ✔️
  • Synthesis and anticonvulsant activity of new 2-(substituted aryl/heteryl)-3-(substituted arylidenimino)-6, 8-dibromo-1, 2, 3, 4-tetrahydroquinazolin-4 (3H)-one derivatives – Cited by: 12, Year: 2006 ⚡
  • Synthesis and pharmacological evaluation of some indanone-3-acetic acid derivatives – Cited by: 11, Year: 2006 📈
  • UV spectrophotometric determination of famciclovir – Cited by: 10, Year: 2007 📊
  • Simultaneous determination of lafutadine and domperidone in capsule by high performance liquid chromatography – Cited by: 9, Year: 2012 💼